Literature DB >> 6601550

Correlation of antibody to rheumatoid arthritis associated nuclear antigen and immune complexes to disease activity in patients with rheumatoid arthritis.

M A Alspaugh, D Rosenstock, J J Biundo, R C Gupta.   

Abstract

Twenty-seven patients with rheumatoid arthritis (RA) maintained on drug regimens were studied monthly for 6-10 months. Disease activity was assessed and levels of anti-RA associated nuclear antigen (RANA) and immune complexes were determined. Anti-RANA generally paralleled disease activity in 64% of cases. Immune complex levels paralleled disease activity in 56% of cases and paralleled anti-RANA in 52% of patients. Immune complexes paralleled anti-RANA together with disease activity in only 33% of patients. Anti-RANA and/or immune complex levels paralleled disease activity indices in 82% of cases. Significant fluctuations (greater than or equal to four-fold) in anti-RANA were frequently found (65%) and were associated with concordant changes in immune complex levels 50% of the time and with changes in disease activity indices 59% of the time. The data suggest that levels of anti-RANA and immune complexes may be important in RA and warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601550      PMCID: PMC1536875     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis; theoretic and clinical considerations.

Authors:  J LANSBURY
Journal:  Arthritis Rheum       Date:  1958-12

2.  Rheumatoid factor as a cause of positive reactions in tests for Epstein-Barr virus-specific IgM antibodies.

Authors:  G Henle; E T Lennette; M A Alspaugh; W Henle
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

3.  Cryoimmunoglobulinemia in rheumatoid arthritis. Significance in serum of patients with rheumatoid vasculitis.

Authors:  M Weisman; N Zvaifler
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

Review 4.  The biology and detection of immune complexes.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

5.  Circulating immune complexes in systemic lupus erythematosus. Association with other immunologic abnormalities but not with changes in renal function.

Authors:  K A Huston; R C Gupta; J V Donadio; F C McDuffie; D M Ilstrup
Journal:  J Rheumatol       Date:  1978       Impact factor: 4.666

6.  Anti-SS-A antibody and other antinuclear antibodies in systemic lupus erythematosus.

Authors:  E Scopelitis; J J Biundo; M A Alspaugh
Journal:  Arthritis Rheum       Date:  1980-03

7.  Rheumatoid vasculitis: effect of cyclophosphamide on the clinical course and levels of circulating immune complexes.

Authors:  T Abel; B S Andrews; P H Cunningham; C M Brunner; J S Davis; D A Horwitz
Journal:  Ann Intern Med       Date:  1980-09       Impact factor: 25.391

8.  Comparison of three immunoassays for immune complexes in rheumatoid arthritis.

Authors:  R C Gupta; F C McDuffie; K A Huston; G Tappeiner; M Meurer; R E Jordon; H S Luthra; G G Hunder; D Ilstrup
Journal:  Arthritis Rheum       Date:  1979-05

9.  Role of immune complexes in rheumatoid polyarteritis.

Authors:  J B Farrell; D A Person; R D Rossen; M D Lidsky
Journal:  Ann Rheum Dis       Date:  1979-08       Impact factor: 19.103

10.  Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect.

Authors:  J M Depper; H G Bluestein; N J Zvaifler
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

View more
  2 in total

Review 1.  Etiology of rheumatoid arthritis.

Authors:  T Kouri
Journal:  Experientia       Date:  1985-04-15

2.  Complete protein sequences of the variable regions of the cloned heavy and light chains of a human anti-cytomegalovirus antibody reveal a striking similarity to human monoclonal rheumatoid factors of the Wa idiotypic family.

Authors:  M M Newkirk; H Gram; G F Heinrich; L Ostberg; J D Capra; R L Wasserman
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.